echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > J Renal Nutr: It can not only control sugar but also delay the progress of "fatty kidney", you deserve this drug!

    J Renal Nutr: It can not only control sugar but also delay the progress of "fatty kidney", you deserve this drug!

    • Last Update: 2021-12-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    It is well known that ectopic lipid accumulation in the kidney (fatty kidney) is a potential driver of diabetic nephropathy, and strict blood sugar control can reduce the risk of diabetic nephropathy


    It is well known that ectopic lipid accumulation in the kidney (fatty kidney) is a potential driver of diabetic nephropathy, and strict blood sugar control can reduce the risk of diabetic nephropathy


    In this single-center parallel group trial, patients with type 2 diabetes were randomly divided into liraglutide group or placebo group and added standard treatment ( metformin /sulfonylurea derivative/insulin)


    Metformin

    The baseline analysis included 50 patients with type 2 diabetes (mean age 56.


    Results after 26 weeks of blood sugar control

    Results after 26 weeks of blood sugar control

    Liraglutide or placebo added to the baseline and results after 26 weeks of conventional blood glucose treatment

    Liraglutide or placebo added to the baseline and results after 26 weeks of conventional blood glucose treatment

    Regardless of the treatment group, after 26 weeks of blood glucose control, the log-transformed RTGC was -0.


    Taking into account the existence of GLP1 receptors in the kidney, the direct pathway related to GLP1 activation is to inhibit various damage pathways in the kidney, including oxidative stress (inhibition of nicotinamide adenine dinucleotide phosphate oxidase), inflammation (cytokines and cytokines).


    The direct pathway related to GLP1 activation is to inhibit various damage pathways in the kidney, including oxidative stress (inhibition of nicotinamide adenine dinucleotide phosphate oxidase), inflammation (decreased expression of cytokines and chemokines), and fibrosis (The expression of transforming growth factor-β1 and type IV collagen is reduced)


    In this exploratory study, it was found that 26 weeks of blood glucose control can reduce RTGC, especially liraglutide


    https://doi.
    org/10.
    1053/j.
    jrn.
    2020.
    09.
    006.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.